Christian Lindknud
@lindknud.bsky.social
Dane 🇩🇰 based in Lyon, France 🇫🇷 and mostly working out of Ghent, Belgium 🇧🇪 to cover the World 🌍; professional growth hacker and strategic comms head
Reposted by Christian Lindknud
🌟 Breaking news: Fujirebio receives US FDA marketing clearance for Lumipulse® G pTau 217/β-Amyloid 1-42 Plasma Ratio in-vitro diagnostic test as an aid to identify patients with amyloid pathology associated with Alzheimer's disease.
Our full press release is here 👉 www.fujirebio.com/en/news-even...
Our full press release is here 👉 www.fujirebio.com/en/news-even...
May 17, 2025 at 6:02 AM
🌟 Breaking news: Fujirebio receives US FDA marketing clearance for Lumipulse® G pTau 217/β-Amyloid 1-42 Plasma Ratio in-vitro diagnostic test as an aid to identify patients with amyloid pathology associated with Alzheimer's disease.
Our full press release is here 👉 www.fujirebio.com/en/news-even...
Our full press release is here 👉 www.fujirebio.com/en/news-even...
Reposted by Christian Lindknud
Meet with us 🤝 at BIOMED-J, les journées pour l'avenir de la biologie médicale, on May 14th and 15th in Paris, France !
More information here 👉 www.fujirebio.com/en/news-even...
More information here 👉 www.fujirebio.com/en/news-even...
May 12, 2025 at 10:07 AM
Meet with us 🤝 at BIOMED-J, les journées pour l'avenir de la biologie médicale, on May 14th and 15th in Paris, France !
More information here 👉 www.fujirebio.com/en/news-even...
More information here 👉 www.fujirebio.com/en/news-even...